首页> 外文期刊>Microbiologia Medica >Pre-analytical and post-analytical evaluation in the era of molecular diagnosis of sexually transmitted diseases: cellularity control and internal control
【24h】

Pre-analytical and post-analytical evaluation in the era of molecular diagnosis of sexually transmitted diseases: cellularity control and internal control

机译:性传播疾病分子诊断时代的分析前和分析后评估:细胞控制和内部控制

获取原文
           

摘要

Background . Increase of molecular tests performed on DNA extracted from various biological materials should not be carried out without an adequate standardization of the pre-analytical and post-analytical phase. Materials and Methods . Aim of this study was to evaluate the role of internal control (IC) to standardize pre-analytical phase and the role of cellularity control (CC) in the suitability evaluation of biological matrices, and their influence on false negative results. 120 cervical swabs (CS) were pre-treated and extracted following 3 different protocols. Extraction performance was evaluated by amplification of: IC, added in each mix extraction; human gene HPRT1 (CC) with RT-PCR to quantify sample cellularity; L1 region of HPV with SPF10 primers. 135 urine, 135 urethral swabs, 553 CS and 332 ThinPrep swabs (TP) were tested for C. trachomatis (CT) and U. parvum (UP) with RT-PCR and for HPV by endpoint-PCR. Samples were also tested for cellularity. Results . Extraction protocol with highest average cellularity (Ac)/sample showed lowest number of samples with inhibitors; highest HPV positivity was achieved by protocol with greatest Ac/PCR. CS and TP under 300.000 cells/sample showed a significant decrease of UP (P<0.01) and HPV (P<0.005) positivity. Female urine under 40.000 cells/mL were inadequate to detect UP (P<0.05). Conclusions . Our data show that IC and CC allow optimization of pre-analytical phase, with an increase of analytical quality. Cellularity/sample allows better sample adequacy evaluation, crucial to avoid false negative results, while cellularity/PCR allows better optimization of PCR amplification. Further data are required to define the optimal cut-off for result normalization.
机译:背景 。没有对分析前和分析后阶段进行适当的标准化,就不应增加对从各种生物材料中提取的DNA进行的分子测试的力度。材料和方法 。这项研究的目的是评估内部控制(IC)在标准化分析前阶段中的作用以及细胞控制(CC)在生物基质适用性评估中的作用及其对假阴性结果的影响。按照3种不同的方案对120枚宫颈拭子(CS)进行了预处理和提取。提取性能通过以下方法进行评估:IC,在每次混合提取中添加;具有RT-PCR的人类基因HPRT1(CC)可以定量样品的细胞流动性;带有SPF10引物的HPV L1区。用RT-PCR检测了135尿液,135尿道拭子,553 CS和332 ThinPrep拭子(TP)的沙眼衣原体(CT)和细小U. parvum(UP),并通过终点PCR检测了HPV。还测试样品的细胞性。结果。平均细胞数(Ac)/样品最高的提取方案显示,含有抑制剂的样品数量最少; HPV阳性率最高的方案是通过最大的Ac / PCR实现的。在300.000个细胞/样品下的CS和TP显示UP(P <0.01)和HPV(P <0.005)阳性率显着降低。低于40.000个细胞/ mL的女性尿液不足以检测UP(P <0.05)。结论。我们的数据表明,IC和CC可以优化分析前相,并提高分析质量。细胞/样品允许更好的样品充分性评估,这对于避免假阴性结果至关重要,而细胞/ PCR可以更好地优化PCR扩增。需要更多数据来定义用于结果归一化的最佳截止值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号